EMJ GOLD

Novartis is partnering with Atropos Health to develop AI models that accelerate rare disease diagnosis, starting with a rare blood disorder.

HonorHealth appoints Dr Nicholas Schork to lead AI-driven disease interception research, reflecting an industry shift towards prevention.

AstraZeneca and Viseven win the 2025 HBA ACE Awards for innovative workforce and community programmes shaping the future of healthcare.

AbbVie to invest $195m in manufacturing expansion as pharma rushes to boost domestic capacity ahead of expected drug import tariffs.

Bayer announces deal with Kumquat for a pancreatic cancer KRAS inhibitor, plus, promising mRNA vaccine research emerges from Phase 1 trial.

Ireland could become a global leader in FemTech innovation, but only if it acts now, claims a new report by Health Innovation Hub Ireland.

A patient case study has uncovered a potential link between beta-HPV and the common skin cancer, cutaneous squamous cell carcinoma (cSCC).

NHS launches the first gonorrhoea vaccine programme in England to reduce infections and tackle the rise of antibiotic resistance.

Two major health agencies are facing leadership reshuffles, with the resignations of the FDA’s Vinay Prasad and NICE’s Dr Sam Roberts. 

From concerning statistics on global health outcomes to new insights on AI and RWD, there’s plenty to discover.

Explore the evolving role of MDMA, LSD and psilocybin in traditional medical research, particularly in the realm of mental health.

Bristol Myers Squibb announces the appointment of Dr Cristian Massacesi as Executive Vice President, Chief Medical Officer and Head of Development.

Laura McMullin, General Manager, Daiichi Sankyo UK, has been appointed the new Vice President of the ABPI.

WHO and UNICEF report finds that global childhood vaccination coverage held steady in 2024, but that worrying gaps remain.

A new survey has found that the use of AI and real-world data (RWD) is on the rise across the biopharma industry, but hurdles remain.

While genomics is best known for its role advancing precision medicine, MGI Tech has pioneered a new use case in enviromental sustainability.

UNAIDS report warns the US funding collapse could risk millions of new infections and deaths unless countries transform their HIV responses.

Sanofi is sponsoring the event for the second year in a row, which brings together 1,000 transplant recipients and live donors to compete.

A report has found that while many in the UK live with rare diseases, systemic failures continue to restrict progress in treatment.

Explore the latest technology that is changing the pharma industry, and discover how these innovations could solve key health challenges.

From new industry M&As to insights on how to recruit Gen Z talent, there’s plenty to discover in our latest pharma news round up.

Rising one place to number one overall, the British drugmaker has overtaken the NHS as the preferred destination for these graduates.

Stefan Oelrich has been newly elected President of the EFPIA, as new leadership calls for action to restore Europe’s global leadership in pharma innovation.

The body is eliminating of Risk Evaluation and Mitigation Strategies for all currently approved BCMA- and CD19-directed CAR T-cell therapies.

Ascroft brings more than 30 years of industry experience, including senior roles at Takeda Pharmaceuticals.

The US plans to stop its financial contributions to Gavi, the Vaccine Alliance, marking an end to an over 20-year partnership.

The survey found that, while 57% of patients support the use of AI in the examination room, they are less enthusiastic about diagnostics.

The FDA has launched an immediate review of clinical trials involving the export of American patients’ living cells to China and other “hostile countries”.

A UK project has received a £1.8m to transform how medicines are made, aiming to make drug manufacturing faster, cleaner and more responsive.

The UK government has set out a 10 Year Health Plan, promising to transform clinical trials and make the UK a scientific superpower.

A £300m bond has been issued by the International Finance Facility for Immunisation to fund vaccine programmes in lower-income countries.

New Ipsos data shows that while 58% of UK adults are willing to join clinical trials, this drops to 41% among ethnic minority adults.

The UK will hike statutory payment rates for branded drugs to over 30% in 2025, far surpassing other European markets and raising concerns.

According to new research from the ABPI, pharma companies need to modernise their outreach strategies.

Vantive has announced the five-year, major investment to expand its R&D and manufacturing capabilities.

Sanofi is set to acquire Blueprint Medicines, a US-based biopharmaceutical company specialising in systemic mastocytosis.

The King’s Fund in the UK has released an updated explainer on the availability of new medicines in the UK’s NHS.

The Paris biotech aims to improve biologic drugs by mastering glycan control, aiming for safer, more effective therapies.

Catch up on May’s key pharma news, research updates and policy shifts.

BioNTech is set to invest up to £1bn in the UK over the next decade, establishing new R&D and AI hubs.